These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28661444)

  • 1. Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates.
    Bavaro T; Tengattini S; Piubelli L; Mangione F; Bernardini R; Monzillo V; Calarota S; Marone P; Amicosante M; Pollegioni L; Temporini C; Terreni M
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28661444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.
    Tengattini S; Domínguez-Vega E; Temporini C; Terreni M; Somsen GW
    Anal Bioanal Chem; 2016 Sep; 408(22):6123-32. PubMed ID: 27372716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope and affinity determination of recombinant Mycobacterium tuberculosis Ag85B antigen towards anti-Ag85 antibodies using proteolytic affinity-mass spectrometry and biosensor analysis.
    Rinaldi F; Lupu L; Rusche H; Kukačka Z; Tengattini S; Bernardini R; Piubelli L; Bavaro T; Maeser S; Pollegioni L; Calleri E; Przybylski M; Temporini C
    Anal Bioanal Chem; 2019 Jan; 411(2):439-448. PubMed ID: 30498982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.
    Shi S; Yu L; Sun D; Liu J; Hickey AJ
    Pharm Res; 2010 Feb; 27(2):224-34. PubMed ID: 19862606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-mass spectrometry structural characterization of neo glycoproteins aiding the rational design and synthesis of a novel glycovaccine for protection against tuberculosis.
    Temporini C; Bavaro T; Tengattini S; Serra I; Marrubini G; Calleri E; Fasanella F; Piubelli L; Marinelli F; Pollegioni L; Speranza G; Massolini G; Terreni M
    J Chromatogr A; 2014 Nov; 1367():57-67. PubMed ID: 25282312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
    Ong E; He Y; Yang Z
    Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic characterization of dimorphic surface protein in Mycobacterium tuberculosis.
    Matsuba T; Siddiqi UR; Hattori T; Nakajima C; Fujii J; Suzuki Y
    FEMS Microbiol Lett; 2016 May; 363(10):. PubMed ID: 27190237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification of potential antigenic proteins and promiscuous CTL epitopes in Mycobacterium tuberculosis.
    Sundaramurthi JC; Brindha S; Shobitha SR; Swathi A; Ramanandan P; Hanna LE
    Infect Genet Evol; 2012 Aug; 12(6):1312-8. PubMed ID: 22484107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
    Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.
    Davila J; McNamara LA; Yang Z
    PLoS One; 2012; 7(7):e40882. PubMed ID: 22815851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel immunogenic Mycobacterium tuberculosis peptides that stimulate mononuclear cells from immune donors.
    Moran AJ; Doran JL; Wu J; Treit JD; Ekpo P; Kerr VJ; Roberts AD; Orme IM; Galant S; Ress SR; Nano FE
    FEMS Microbiol Lett; 1999 Aug; 177(1):123-30. PubMed ID: 10436930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of B cell epitopes on the 16K antigen of Mycobacterium tuberculosis.
    Verbon A; Hartskeerl RA; Moreno C; Kolk AH
    Clin Exp Immunol; 1992 Sep; 89(3):395-401. PubMed ID: 1381300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
    Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
    Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
    Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
    Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against
    Rinaldi F; Tengattini S; Piubelli L; Bernardini R; Mangione F; Bavaro T; Paone G; Mattei M; Pollegioni L; Filice G; Temporini C; Terreni M
    RSC Adv; 2018 Jun; 8(41):23171-23180. PubMed ID: 35540174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach.
    Meza B; Ascencio F; Sierra-Beltrán AP; Torres J; Angulo C
    Infect Genet Evol; 2017 Apr; 49():309-317. PubMed ID: 28185986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico predicted mycobacterial epitope elicits in vitro T-cell responses.
    Khan MK; Zaman S; Chakraborty S; Chakravorty R; Alam MM; Bhuiyan TR; Rahman MJ; Fernández C; Qadri F; Seraj ZI
    Mol Immunol; 2014 Sep; 61(1):16-22. PubMed ID: 24853589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.